ARO-ANG3

Study of ARO-ANG3 in Healthy Volunteers and in Dyslipidemic Patients

Study of ARO-ANG3 in Adults With Mixed Dyslipidemia

Phase 3 Study to Evaluate the Efficacy and Safety of Zodasiran in Adolescent and Adult Subjects with Homozygous Familial Hypercholesterolemia (YOSEMITE)

Phase 3 Single-Arm Open-Label Study to Evaluate the Efficacy and Safety of Zodasiran in Adolescent Subjects (age 12 to <18 years) with Homozygous Familial Hypercholesterolemia (SPRUCE)